519 related articles for article (PubMed ID: 18927957)
21. Update on Botulinum Toxin.
Carruthers A
Skin Therapy Lett; 1999; 4(5):1-2. PubMed ID: 10751835
[TBL] [Abstract][Full Text] [Related]
22. Topical botulinum toxin to treat hyperhidrosis? No sweat!
Lim EC; Seet RC; Chow A; Oh VM; Ong BK; Wilder-Smith EP
Med Hypotheses; 2006; 67(1):27-32. PubMed ID: 16524669
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin: clinical use.
Truong DD; Jost WH
Parkinsonism Relat Disord; 2006 Sep; 12(6):331-55. PubMed ID: 16870487
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
Gibson N; Graham HK; Love S
Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
[TBL] [Abstract][Full Text] [Related]
25. [A new possibility for focal treatment of spasticity with botulinum neurotoxin. The Danish Society of Neurology].
Jeppesen LL; Dalager T; Meden P
Ugeskr Laeger; 2004 Mar; 166(12):1117. PubMed ID: 15067776
[No Abstract] [Full Text] [Related]
26. [Botulinum: fashionable drug and effective medication. What the "miracle weapon against crow's feet" can do in addition].
Stiefelhagen P
MMW Fortschr Med; 2003 Apr; 145(14):4-6. PubMed ID: 15072266
[No Abstract] [Full Text] [Related]
27. [Use of botulinum neurotoxin for spasticity].
Mukai Y; Kaji R
Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin in clinical practice.
Hughes AJ
Drugs; 1994 Dec; 48(6):888-93. PubMed ID: 7533696
[TBL] [Abstract][Full Text] [Related]
29. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
Kreyden OP; Scheidegger EP
Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
[TBL] [Abstract][Full Text] [Related]
30. [Botulinum toxin in the treatment of pain].
Domzał TM
Neurol Neurochir Pol; 1998; 32 Suppl 1():57-60. PubMed ID: 9608554
[TBL] [Abstract][Full Text] [Related]
31. [Current indications for the treatment with botulin toxin].
Kohler A; Ochsner F
Rev Med Suisse Romande; 2001 Jun; 121(6):471-4. PubMed ID: 11490978
[TBL] [Abstract][Full Text] [Related]
32. Contraindications and complications with the use of botulinum toxin.
Klein AW
Clin Dermatol; 2004; 22(1):66-75. PubMed ID: 15158548
[TBL] [Abstract][Full Text] [Related]
33. [Clinical application of botulinum toxin].
Grandas F
Neurologia; 1995; 10(6):224-33. PubMed ID: 7546812
[No Abstract] [Full Text] [Related]
34. [Botulinum toxin in tension-type headache].
Jost WH
Fortschr Neurol Psychiatr; 2003 Jun; 71(6):296-305. PubMed ID: 12796849
[TBL] [Abstract][Full Text] [Related]
35. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
[TBL] [Abstract][Full Text] [Related]
36. Botox: beyond wrinkles.
Carruthers J; Carruthers A
Clin Dermatol; 2004; 22(1):89-93. PubMed ID: 15158551
[TBL] [Abstract][Full Text] [Related]
37. [Botulinum toxin in specific pain therapy].
Göbel H; Jost WH;
Schmerz; 2003 Apr; 17(2):149-65. PubMed ID: 12695898
[TBL] [Abstract][Full Text] [Related]
38. The use of botulinum toxin in physical medicine and rehabilitation.
Cuevas-Trisán RL; Cruz-Jiménez M
Bol Asoc Med P R; 2006; 98(1):42-55. PubMed ID: 19610549
[TBL] [Abstract][Full Text] [Related]
39. [Current status and prospects of medical therapy for dystonia].
Osawa M
Rinsho Shinkeigaku; 2006 Nov; 46(11):967-9. PubMed ID: 17432235
[TBL] [Abstract][Full Text] [Related]
40. Dose standardization of botulinum toxin.
Van den Bergh PY; Lison DF
Adv Neurol; 1998; 78():231-5. PubMed ID: 9750920
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
